Construction of a mutant and characterization of the role of the vaccine antigen P6 in outer membrane integrity of nontypeable Haemophilus influenzae

Infection and Immunity

Volumn 74, Issue 9, 2006, Pages 5169-5176

  Murphy, Timothy F ^a,b   Kirkham, Charmaine ^a   Lesse, Alan J ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL ANTIGEN; BACTERIAL VACCINE; CEFDINIR; CEFPODOXIME; CEFPROZIL; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CLARITHROMYCIN; CLAVULANIC ACID; LEVOFLOXACIN; LIPOPROTEIN; MEROPENEM; MOXIFLOXACIN; MUTANT PROTEIN; NOVOBIOCIN; OUTER MEMBRANE PROTEIN; PEPTIDOGLYCAN; POLYMYXIN B; PROTEIN P6; TELITHROMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIUM COLONY; CELL MUTANT; CELL SIZE; CELL STRUCTURE; CELL VACUOLE; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DRUG MECHANISM; ELECTRON MICROSCOPY; GENE CASSETTE; GENETIC COMPLEMENTATION; GRAM NEGATIVE BACTERIUM; GROWTH RATE; HAEMOPHILUS INFLUENZAE; IMMUNE RESPONSE; IN VITRO STUDY; NONHUMAN; OTITIS MEDIA; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY TRACT INFECTION; SEQUENCE HOMOLOGY; SERUM; VACCINE PRODUCTION;

ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CELL MEMBRANE; COMPLEMENT SYSTEM PROTEINS; DRUG RESISTANCE, BACTERIAL; GENETIC COMPLEMENTATION TEST; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; MUTATION; SERUM;

EID: 33748053019     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00692-06     Document Type: Article

References (53)

1. Abe, Y., T. F. Murphy, S. Sethi, H. S. Faden, J. Dmochowski, Y. Harabuchi, and Y. M. Thanavala. 2002. Lymphocyte proliferative response to P6 of Haemophilus influenzae is associated with relative protection from exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 165:967-971.
2. Aliprantis, A. O., R. B. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285:736-739.
3. American Thoracic Society. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 152:577-5121.
4. Bakaletz, L. O., B. D. Baker, J. A. Jurcisek, A. Harrison, L. A. Novotny, J. E. Bookwalter, R. Mungur, and R. S. Munson, Jr. 2005. Demonstration of type IV pilus expression and a twitching phenotype by Haemophilus influenzae. Infect. Immun. 73:1635-1643.
5. Berenson, C. S., T. F. Murphy, C. T. Wrona, and S. Sethi. 2005. Outer membrane protein P6 of nontypeable Haemophilus influenzae is a potent and selective inducer of human macrophage proinflammatory cytokines. Infect. Immun. 73:2728-2735.
6. Bertot, G. M., P. D. Becker, C. A. Guzman, and S. Grinstein. 2004. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae. J. Infect. Dis. 189:1304-1312.
7. Brightbill, H. D., D. H. Libraty, S. R. Krutzik, R. B. Yang, J. T. Belisle, J. R. Bleharski, M. Maitland, M. V. Norgard, S. E. Plevy, S. T. Smale, P. J. Brennan, B. R. Bloom, P. J. Godowski, and R. L. Modlin. 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285:732-736.
8. Cascales, E., and R. Lloubes. 2004. Deletion analyses of the peptidoglycan-associated lipoprotein Pal reveals three independent binding sequences including a TolA box. Mol. Microbiol. 51:873-885.
9. Casey, J. R., and M. E. Pichichero. 2004. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr. Infect. Dis. J. 23:824-828.
10. Chen, R., and U. Henning. 1987. Nucleotide sequence of the gene for the peptidoglycan-associated lipoprotein of Escherichia coli K12. Eur. J. Biochem. 163:73-77.
11. Chen, R., J. H. Lim, H. Jono, X. X. Gu, Y. S. Kim, C. B. Basbaum, T. F. Murphy, and J. D. Li. 2004. Nontypeable Haemophilus influenzae lipoprotein P6 induces MUC5AC mucin transcription via TLR2-TAK1-dependent p38 MAPK-AP1 and IKKbeta-IkappaBalpha-NF-kappaB signaling pathways. Biochem. Biophys. Res. Commun. 324:1087-1094.
12. DeMaria, T. F., D. M. Murwin, and E. R. Leake. 1996. Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media. Infect. Immun. 64:5187-5192.
13. Dennis, J. J., E. R. Lafontaine, and P. A. Sokol. 1996. Identification and characterization of the tolQRA genes of Pseudomonas aeruginosa. J. Bacteriol. 178:7059-7068.
14. Dubuisson, J. F., A. Vianney, N. Hugouvieux-Cotte-Pattat, and J. C. Lazzaroni. 2005. Tol-Pal proteins are critical cell envelope components of Erwinia chrysanthemi affecting cell morphology and virulence. Microbiology 151:3337-3347.
15. Fortney, K. R., R. S. Young, M. E. Bauer, B. P. Katz, A. F. Hood, R. S. Munson, Jr., and S. M. Spinola. 2000. Expression of peptidoglycan-associated lipoprotein is required for virulence in the human model of Haemophilus ducreyi infection. Infect. Immun. 68:6441-6448.
16. Giebink, G. S., Y. Kurono, L. O. Bakaletz, J. M. Kyd, S. J. Barenkamp, T. F. Murphy, B. Green, P. L. Ogra, X. X. Gu, J. A. Patel, T. Heikkinen, S. I. Pelton, M. Hotomi, and P. Karma. 2005. Recent advances in otitis media. 6. Vaccine. Ann. Otol. Rhinol. Laryngol. 194(Suppl.):86-103.
17. Green, B. A., T. Quinn-Dey, and G. W. Zlotnick. 1987. Biologic activities of antibody to a peptidoglycan-associated lipoprotein of Haemophilus influenzae against multiple clinical isolates of H. influenzae type b. Infect. Immun. 55:2878-2883.
18. Green, B. A., M. E. Vazquez, G. W. Zlotnick, G. Quigley-Reape, J. D. Swarts, I. Green, J. L. Cowell, C. D. Bluestone, and W. J. Doyle. 1993. Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model. Infect. Immun. 61:1950-1957.
19. Heilmann, K. P., C. L. Rice, A. L. Miller, N. J. Miller, S. E. Beekmann, M. A. Pfaller, S. S. Richter, and G. V. Doern. 2005. Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States. Antimicrob. Agents Chemother. 49:2561-2564.
20. Herriott, R. M., E. M. Meyer, and M. Vogt. 1970. Defined nongrowth media for stage II development of competence in Haemophilus influenzae. J. Bacteriol. 101:517-524.
21. Hotomi, M., T. Saito, and N. Yamanaka. 1998. Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin. Vaccine 16:1950-1956.
22. Hotomi, M., N. Yamanaka, T. Saito, J. Shimada, M. Suzumoto, M. Suetake, and H. Faden. 1999. Antibody responses to the outer membrane protein P6 of non-typeable Haemophilus influenzae and pneumococcal capsular polysaccharides in otitis-prone children. Acta Otolaryngol. (Stockholm) 119:703-707.
23. Hotomi, M., N. Yamanaka, J. Shimada, M. Suzumoto, Y. Ikeda, A. Sakai, J. Arai, and B. Green. 2002. Intranasal immunization with recombinant outer membrane protein P6 induces specific immune responses against nontypeable Haemophilus influenzae. Int. J. Pediatr. Otorhinolaryngol. 65:109-116.
24. Kilpi, T., E. Herva, T. Kaijalainen, R. Syrjanen, and A. K. Takala. 2001. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr. Infect. Dis. J. 20:654-662.
25. Klein, J. O. 1994. Otitis media. Clin. Infect. Dis. 19:823-833.
26. Kodama, H., H. Faden, Y. Harabuchi, A. Kataura, J. M. Bernstein, and L. Brodsky. 1999. Cellular immune response of adenoidal and tonsillar lymphocytes to the P6 outer membrane protein of non-typeable Haemophilus influenzae and its relation to otitis media. Acta Otolaryngol. (Stockholm) 119:377-383.
27. Kyd, J. M., M. L. Dunkley, and A. W. Cripps. 1995. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model. Infect. Immun. 63:2931-2940.
28. Lazzaroni, J. C., and R. Portalier. 1992. The excC gene of Escherichia coli K-12 required for cell envelope integrity encodes the peptidoglycan- associated lipoprotein (PAL). Mol. Microbiol. 6:735-742.
29. Leibovitz, E., M. R. Jacobs, and R. Dagan. 2004. Haemophilus influenzae: a significant pathogen in acute otitis media. Pediatr. Infect. Dis. J. 23:1142-1152.
30. Liang, M. D., A. Bagchi, H. S. Warren, M. M. Tehan, J. A. Trigilio, L. K. Beasley-Topliffe, B. L. Tesini, J. C. Lazzaroni, M. J. Fenton, and J. Hellman. 2005. Bacterial peptidoglycan-associated lipoprotein: a naturally occurring Toll-like receptor 2 agonist that is shed into serum and has synergy with lipopolysaccharide. J. Infect. Dis. 191:939-948.
31. Luke, N. R., S. Allen, B. W. Gibson, and A. A. Campagnari. 2003. Identification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutant. Infect. Immun. 71:6426-6434.
32. Mason, K. W., D. Zhu, C. A. Scheuer, J. C. McMichael, G. W. Zlotnick, and B. A. Green. 2004. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529. Vaccine 22:3449-3456.
33. Munson, R. S., Jr., and D. M. Granoff. 1985. Purification and partial characterization of outer membrane proteins P5 and P6 from Haemophilus influenzae type b. Infect. Immun. 49:544-549.
34. Munson, R. S., Jr., S. Grass, and R. West. 1993. Molecular cloning and sequence of the gene for outer membrane protein P5 of Haemophilus influenzae. Infect. Immun. 61:4017-4020.
35. Murphy, T. F. 2003. Respiratory infections caused by non-typeable Haemophilus influenzae. Curr. Opin. Infect. Dis. 16:129-134.
36. Murphy, T. F. 2005. Vaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges. Expert Rev. Vaccines 4:843-853.
37. Murphy, T. F., L. O. Bakaletz, J. M. Kyd, B. Watson, and D. L. Klein. 2005. Vaccines for otitis media: proposals for overcoming obstacles to progress. Vaccine 23:2696-2702.
38. Murphy, T. F., L. C. Bartos, P. A. Rice, M. B. Nelson, K. C. Dudas, and M. A. Apicella. 1986. Identification of a 16,600-dalton outer membrane protein on nontypable Haemophilus influenzae as a target for human serum bactericidal antibody. J. Clin. Investig. 78:1020-1027.
39. Murphy, T. F., K. C. Dudas, J. M. Mylotte, and M. A. Apicella. 1983. A subtyping system for nontypable Haemophilus influenzae based on outer-membrane proteins. J. Infect. Dis. 147:838-846.
40. Murphy, T. F., and C. Kirkham. 2002. Biofilm formation by nontypeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pili. BMC Microbiol. 2:7.
41. Murphy, T. F., M. B. Nelson, K. C. Dudas, J. M. Mylotte, and M. A. Apicella. 1985. Identification of a specific epitope of Haemophilus influenzae on a 16,600-dalton outer membrane protein. J. Infect. Dis. 152:1300-1307.
42. Nelson, M. B., M. A. Apicella, T. F. Murphy, H. Vankeulen, L. D. Spotila, and D. Rekosh. 1988. Cloning and sequencing of Haemophilus influenzae outer membrane protein P6. Infect. Immun. 56:128-134.
43. Nelson, M. B., R. S. Munson, Jr., M. A. Apicella, D. J. Sikkema, J. P. Molleston, and T. F. Murphy. 1991. Molecular conservation of the P6 outer membrane protein among strains of Haemophilus influenzae: analysis of antigenic determinants, gene sequences, and restriction fragment length polymorphisms. Infect. Immun. 59:2658-2663.
44. Parsons, L. M., F. Lin, and J. Orban. 2006. Peptidoglycan recognition by Pal, an outer membrane lipoprotein. Biochemistry 45:2122-2128.
45. Parsons, L. M., and J. Orban. 2005. NMR assignment of the periplasmic domain of peptidoglycan-associated lipoprotein (Pal) from Haemophilus influenzae. J. Biomol. NMR 32:93.
46. Pauwels, R. A., A. S. Buist, P. M. Calverley, C. R. Jenkins, and S. S. Hurd. 2001. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am. J. Respir. Crit. Care Med. 163:1256-1276.
47. Poje, G., and R. J. Redfield. 2003. Transformation of Haemophilus influenzae, p. 57-70. In M. Herbert, D. Wood, and E. Moxon (ed.), Haemophilus influenzae protocols. Humana Press, Totowa, N.J.
48. Sabirov, A., S. Kodama, T. Hirano, M. Suzuki, and G. Mogi. 2001. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media. Infect. Immun. 69:2964-2971.
49. Sen, K., D. J. Sikkema, and T. F. Murphy. 1996. Isolation and characterization of the Haemophilus influenzae tolQ, tolR, tolA and tolB genes. Gene 178:75-81.
50. Sethi, S., and T. F. Murphy. 2001. Bacterial infection in chronic obstructive pulmonary disease in 2000. A state of the art review. Clin. Microbiol. Rev. 14:336-363.
51. Shuto, T., H. Xu, B. Wang, J. Han, H. Kai, X. X. Gu, T. F. Murphy, D. J. Lim, and J. D. Li. 2001. Activation of NF-kappa B by nontypeable Haemophilus influenzae is mediated by Toll-like receptor 2-TAK1-dependent NIK-IKK alpha/beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc. Natl. Acad. Sci. USA 98:8774-8779.
52. Yamanaka, N., and H. Faden. 1993. Antibody response to outer membrane protein of nontypeable Haemophilus influenzae in otitis-prone children. J. Pediatr. 122:212-218.
53. Yang, Y.-P., R. S. Munson, Jr., S. Grass, P. Chong, R. E. Harkness, L. Gisonni, O. James, Y. Kwok, and M. H. Klein. 1998. Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6. Vaccine 15:976-987.